The AHA Saturday sent the Health Resources and Services Administration a letter requesting clarifications for several elements of the COVID-19 Uninsured Program.

Beginning May 6, 2020, providers may submit claims through the program for uninsured patients’ COVID-19 testing and treatment. The AHA urged HRSA to clarify coding guidance to ensure consistency with International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) guidelines, as well as reimbursement rates and timing for submitting certain claims. 

Read the AHA Special Bulletin for more details.

Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…
Headline
The AHA provided recommendations to the Food and Drug Administration Dec. 1 in response to a request for information on the measurement and evaluation of…
Headline
The Food and Drug Administration has identified a Class I recall of Baxter Life2000 Ventilation Systems due to a cybersecurity issue discovered through…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…